Literature DB >> 23010825

T-cell inhibitors: a bench-to-bedside review.

Shinjita Das1, Kiyoshi Ariizumi, Ponciano D Cruz.   

Abstract

Allergic contact dermatitis is the quintessential example of a delayed-in-time and T-cell-mediated immune response. In the last decade, many of the molecular events required to initiate (or block) such a response have been uncovered. Textbook and journal reviews have emphasized the costimulatory requirements, with less focus on the coinhibitory signals that are of equal importance in understanding this central event of adaptive immunity. To fill this gap, we offer a compendium of discoveries characterizing the ligand-receptor pairs inhibiting T-cell activation and of selected illnesses and therapeutic applications that illuminate their role in health and disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010825      PMCID: PMC3485635          DOI: 10.1097/DER.0b013e31826e43ed

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  79 in total

1.  Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans.

Authors:  S Shikano; M Bonkobara; P K Zukas; K Ariizumi
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

2.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

Authors:  Lino C Gonzalez; Kelly M Loyet; Jill Calemine-Fenaux; Vandana Chauhan; Bernd Wranik; Wenjun Ouyang; Dan L Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

3.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

4.  A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.

Authors:  Eric Kai-Pang Kong; Ludmila Prokunina-Olsson; Wilfred Hing-Sang Wong; Chak-Sing Lau; Tak-Mao Chan; Marta Alarcón-Riquelme; Yu-Lung Lau
Journal:  Arthritis Rheum       Date:  2005-04

5.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

6.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

7.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

8.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

9.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

Authors:  H Nishimura; M Nose; H Hiai; N Minato; T Honjo
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

10.  Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.

Authors:  Carole L Berger; Robert Tigelaar; Justine Cohen; Kavita Mariwalla; Jennifer Trinh; Nianci Wang; Richard L Edelson
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

View more
  1 in total

1.  Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation.

Authors:  Qing Zhang; Jicheng Chen; Hanchao Gao; Song Zhang; Chengjiang Zhao; Cuibing Zhou; Chengjun Wang; Yang Li; Zhiming Cai; Lisha Mou
Journal:  Int J Med Sci       Date:  2018-07-13       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.